These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 13344137)

  • 21. [Serum iron parameters in chronic liver diseses].
    Wójtowicz-Chomicz K; Cichoz-Lach H; Lis E; Kowalik A; Słomka M; Celiński K
    Pol Merkur Lekarski; 2013 Aug; 35(206):77-81. PubMed ID: 24052985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case records of the Massachusetts General Hospital. Case 33-2006. A 43-year-old man with diabetes, hypogonadism, cirrhosis, arthralgias, and fatigue.
    Chung RT; Misdraji J; Sahani DV
    N Engl J Med; 2006 Oct; 355(17):1812-9. PubMed ID: 17065644
    [No Abstract]   [Full Text] [Related]  

  • 23. A study of serum iron and total iron binding capacity in hepatic cirrhosis.
    Mehrotra MP; Patney NL; Gupta OP
    Indian J Med Sci; 1976 Sep; 30(9):287-90. PubMed ID: 1032621
    [No Abstract]   [Full Text] [Related]  

  • 24. [Resorption and biotransformation of model substances in primary idiopathic hemochromatosis (siderophilia)].
    Hoffmann A; Müller A; Reinhardt M; Truckenbrodt J; Jorke D
    Gastroenterol J; 1989; 49(3):113-7. PubMed ID: 2629779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation.
    Guggenbuhl P; Deugnier Y; Boisdet JF; Rolland Y; Perdriger A; Pawlotsky Y; Chalès G
    Osteoporos Int; 2005 Dec; 16(12):1809-14. PubMed ID: 15928800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
    Chayvialle JA; Brissot P; Pelletier MJ; Hita de Nercy Y; Lambert R; Bourel M
    Digestion; 1977; 16(1-2):118-27. PubMed ID: 79512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient hepatic deposition of iron im primary hemochromatosis with iron deficiency following venesection.
    Pollycove M; Fawwaz RA; Winchell HS
    J Nucl Med; 1971 Jan; 12(1):28-30. PubMed ID: 5539902
    [No Abstract]   [Full Text] [Related]  

  • 28. [Atransferrinemia secondary to hepatic cirrhosis, hemochromatosis, and nephrotic syndrome].
    Gaston Morata JL; Rodríguez Cuartero A; Urbano Jiménez F; González Martínez F; Ampuero Ampuero J
    Rev Esp Enferm Apar Dig; 1982 Dec; 62(6):491-5. PubMed ID: 6189152
    [No Abstract]   [Full Text] [Related]  

  • 29. [The blood serum iron level in chronic hepatitis and cirrhosis of the liver].
    Zikeeva VK
    Klin Med (Mosk); 1965 Nov; 43(11):53-8. PubMed ID: 5874303
    [No Abstract]   [Full Text] [Related]  

  • 30. Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population.
    Aleman S; Endalib S; Stål P; Lööf L; Lindgren S; Sandberg-Gertzén H; Almer S; Olsson S; Danielsson A; Wallerstedt S; Hultcrantz R
    Scand J Gastroenterol; 2011 Sep; 46(9):1118-26. PubMed ID: 21675821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atransferrinemia secondary to hepatic cirrhosis, hemochromatosis, and nephrotic syndrome].
    Gastón Morata JL; Rodríguez Cuartero A; Urbano Jiménez F; González Martínez F; Ampuero Ampuero J
    Rev Esp Enferm Apar Dig; 1982 Dec; 62(6):491-5. PubMed ID: 7187699
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum albumin turnover in liver cirrhosis.
    Bianchi R; Mariani G; Pilo A; Toni MG
    J Nucl Biol Med; 1974; 18(1):20-9. PubMed ID: 4839513
    [No Abstract]   [Full Text] [Related]  

  • 33. [Joint diseases as the early clinical symptom of hemochromatosis].
    Walther B; Zönnchen B; Hehlmann R; Schattenkirchner M
    Fortschr Med; 1981 Mar; 99(10):321-5. PubMed ID: 7216095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of blood serum iron content in liver cirrhosis in children].
    Plaksina GV; Dedikova LA
    Pediatriia; 1974 Mar; 3():31-2. PubMed ID: 4828015
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical significance of intravenous iron addition. II. Elimination rate of intravenously administered iron in chronic disorders of liver parenchyma and liver cirrhosis].
    REICHENBERGER J; HEVELKE G
    Z Gesamte Inn Med; 1956 Mar; 11(5):204-8. PubMed ID: 13325651
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic value of research in the study of the metabolism of iron in hemochromatosis].
    NAPOLITANO L; SCURO LA
    Rass Fisiopatol Clin Ter; 1959 Jun; 31():594-608. PubMed ID: 14425998
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum ceruloplasmin in liver cirrhosis.
    Ventura E; Zeneroli ML; Calandra S
    Gastroenterologia; 1967; 107(6):360-7. PubMed ID: 4167753
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum iron and iron-binding capacity: a round-robin interlaboratory comparison study.
    Blanck HM; Pfeiffer CM; Caudill SP; Reyes M; Gunter EW; Imperatore G; van Assendelft OW; Strider S; Dearth T
    Clin Chem; 2003 Oct; 49(10):1672-5. PubMed ID: 14500597
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA-A3 and serum iron. A study in an Irish control population.
    Stevens FM; Fallon MG; McCarthy CF; Grimes H
    Tissue Antigens; 1983 May; 21(5):402-4. PubMed ID: 6868061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.